Renoprotective effect of febuxostat on contrast-induced acute kidney injury in chronic kidney disease patients stage 3: randomized controlled trial

Abstract Introduction Contrast-induced acute kidney injury (CI-AKI) is known to be a complication of using intravascular contrast injection. Unfortunately, it is associated with adverse outcomes such as prolonged length of hospitalization and increased burden of health care costs. So, we aimed to de...

Full description

Bibliographic Details

Published in:	BMC Nephrology
Main Authors:	Iman Ibrahim Sarhan, Yasser A. Abdellatif, Rania Elsayed Saad, Nahla Mohamed Teama
Format:	Article
Language:	English
Published:	BMC 2023-03-01
Subjects:	Contrast induced acute kidney injury Febuxostat Percutaneous coronary intervention Contrast
Online Access:	https://doi.org/10.1186/s12882-023-03114-4